Patou Gary
Xenon Pharmaceuticals Inc. · Director
Patou Gary is listed in filings as Director at Xenon Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Jun 8, 2026, including sale activity. Recent filings connect the profile to Xenon Pharmaceuticals Inc. (XENE). The current snapshot covers public activity from Nov 22, 2024 to Jun 8, 2026. Reported amounts are shown as $117.2K to $41.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $70k1.3k shares | SellJun 5, 2026 | $53.14 | $66.98 |